Technology News and Research

RSS

Health care leaders to address the value of collaboration and challenges inherent to interoperability

A panel of executives representing public-sector health, health care providers, health care information technology, and health plans will address the value of collaboration and the challenges inherent to interoperability, especially as both topics pertain to health information networks.

7 Nov 2009

Halozyme Therapeutics announces results of its insulin variability study

Halozyme Therapeutics, Inc. today announced insulin variability study results that demonstrated reduced intrasubject absorption variability for the combination of lispro, a meal time analog insulin, plus PH20 (hyaluronidase) compared to subcutaneous injection of lispro alone.

7 Nov 2009

Roper Industries to acquire Verathon

Roper Industries, Inc. (NYSE: ROP) today announced that it has signed a definitive agreement to acquire Verathon, Inc., a leading provider of proprietary medical devices. The Verathon Board of Directors has approved the transaction and the closing is subject to customary regulatory approvals and closing conditions, including shareholder approval. The parties expect the closing to be completed in early December.

7 Nov 2009

Health policy research roundup

Health Affairs: Enrollment Is Driving Medicaid Costs—But Two Targets Can Yield Savings - "Although Medicaid spending has grown faster than the rate of increase in national health spending, much of this is explained by increased enrollment," write the authors of this paper, who present data showing that "[p]er enrollee, Medicaid spending actually compares favorably to increases in medical care prices and gross domestic product."

7 Nov 2009

Nytimes looks at doctors' crucial role in reshaping U.S. health system

Doctors and hospital payment systems remain at the center of the health care reform debate as news outlets examine the benefits of replacing the current fee-for-service approach.

7 Nov 2009

Increased use of CAS procedures to treat carotid stenosis associated with adverse clinical outcomes

Among eligible Medicare beneficiaries, increased use of carotid arterial stenting (CAS) procedures to treat carotid stenosis-the narrowing of the carotid artery-is associated with higher rates of mortality and adverse clinical outcomes, including heart attack and stroke, according to researchers from the University of Pennsylvania School of Medicine.

7 Nov 2009

NIH grants $1 million to study whether Transcendental Meditation can prevent future heart attacks in CHD patients

The National Institutes of Health's National Heart, Lung, and Blood Institute will fund a $1 million collaborative study by the Center for Natural Medicine and Prevention at Maharishi University of Management Research Institute and Columbia University Medical Center to determine whether the stress-reducing Transcendental Meditation technique can help patients with coronary heart disease (CHD) prevent future heart attacks, strokes and death.

7 Nov 2009

GeoVax Labs announces financial results and operational update for the third quarter of 2009

GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced its third quarter 2009 financial results and provided an operational update.

6 Nov 2009

Calbiotech awarded a SBIR contract to develop analyte specific reagents for the diagnosis of Dengue virus

Calbiotech, Inc. announced today that it has been awarded a Small Business Innovative Research (SBIR) Phase I contract by the U.S. Army Medical Research and Material command. Under terms of the agreement, Calbiotech will develop analyte specific reagents (ASRs) for the diagnosis of Dengue virus.

6 Nov 2009

GTC Biotherapeutics announces financial results for third quarter 2009

GTC Biotherapeutics, Inc.’s total net loss for the third quarter ended September 27, 2009 was $5.1 million, or $0.48 per share, compared with $6.1 million, or $0.59 per share, in the third quarter of 2008. The total net loss for the first nine months of 2009 was $26.2 million, or $2.51 per share, compared to $16.5 million, or $1.71 per share, for the first nine months of 2008.

6 Nov 2009

PPMD awards $75,000 grant to University of California professor for Duchenne muscular dystrophy research

Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced today the latest recipient of the End Duchenne Grant Award Program.

6 Nov 2009

KFHP/H and their subsidiaries report total operating revenue of $10.5 billion for the quarter ended September 30, 2009

Kaiser Foundation Health Plan, Inc., Kaiser Foundation Hospitals (KFHP/H), and their subsidiaries reported today a combined total operating revenue of $10.5 billion for the quarter ended September 30, 2009, compared to $10.2 billion in the third quarter of last year.

6 Nov 2009

Third-quarter 2009 financial results announced by Halozyme Therapeutics

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the three and nine months ended September 30, 2009.

6 Nov 2009

55% of adult population in Greater Washington, DC say they will not get H1N1 flu vaccine, reveals poll results

Fifty-five percent of the adult population in the Greater Washington, DC region say they will not get the H1N1 flu vaccine, according to a new poll commissioned by the Greater Washington Board of Trade.

6 Nov 2009

LifePoint Hospitals reports financial results for the third quarter ended September 30, 2009

LifePoint Hospitals, Inc. today announced results for the third quarter and nine months ended September 30, 2009.

6 Nov 2009

Bioniche Life Sciences announces financial results for its Fiscal 2010 first-quarter

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its Fiscal 2010 first quarter, ended September 30, 2009.

6 Nov 2009

Women may not have enough energy to support both hard workouts and getting pregnant: Study

Are you a female athlete - or just someone who likes challenging workouts -- who also wants to get pregnant? It may make sense to ease off a bit as you try to get pregnant. New research from the Norwegian University of Science and Technology (NTNU) shows that the body may not have enough energy to support both hard workouts and getting pregnant.

6 Nov 2009

Data on Puredel's Ossulin to be presented at the San Francisco Diabetes Technology Meeting

The first public data on Ossulin™ a new oral insulin product, will be presented today at the 9th Annual Diabetes Technology Meeting in San Francisco, CA. Ossulin™ is being developed by Puredel Limited, a joint-venture between the European pharmaceutical specialty company CM&D Pharma Limited and Natreon Inc., New Brunswick, NJ., developers of the proprietary delivery platform.

6 Nov 2009

People pay more for products that carry detailed nutritional information than for light items

People would be willing to pay more for products that carry detailed nutritional information than for the so-called light items. Thus it has been confirmed by researchers from the University of Santiago de Compostela (USC) and the Centre for Agro-Food Research and Technology of Aragón (CITA) in a new study on the nutritional labelling of breakfast biscuits.

6 Nov 2009

NYUCN incorporates Epocrates software into its nursing program curriculum

Epocrates, Inc., developer of popular clinical reference and decision support tools, announced today that New York University College of Nursing (NYUCN) will provide its graduate students with the company’s mobile software. Building upon its history of nursing excellence, NYUCN has incorporated Epocrates® software and the use of mobile devices into its comprehensive graduate curriculum.

6 Nov 2009

Technology News and Research

Health care leaders to address the value of collaboration and challenges inherent to interoperability

Halozyme Therapeutics announces results of its insulin variability study

Roper Industries to acquire Verathon

Health policy research roundup

Nytimes looks at doctors' crucial role in reshaping U.S. health system

Increased use of CAS procedures to treat carotid stenosis associated with adverse clinical outcomes

NIH grants $1 million to study whether Transcendental Meditation can prevent future heart attacks in CHD patients

GeoVax Labs announces financial results and operational update for the third quarter of 2009

Calbiotech awarded a SBIR contract to develop analyte specific reagents for the diagnosis of Dengue virus

GTC Biotherapeutics announces financial results for third quarter 2009

PPMD awards $75,000 grant to University of California professor for Duchenne muscular dystrophy research

KFHP/H and their subsidiaries report total operating revenue of $10.5 billion for the quarter ended September 30, 2009

Third-quarter 2009 financial results announced by Halozyme Therapeutics

55% of adult population in Greater Washington, DC say they will not get H1N1 flu vaccine, reveals poll results

LifePoint Hospitals reports financial results for the third quarter ended September 30, 2009

Bioniche Life Sciences announces financial results for its Fiscal 2010 first-quarter

Women may not have enough energy to support both hard workouts and getting pregnant: Study

Data on Puredel's Ossulin to be presented at the San Francisco Diabetes Technology Meeting

People pay more for products that carry detailed nutritional information than for light items

NYUCN incorporates Epocrates software into its nursing program curriculum

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News